Corbion (OTCPK:CSNV.Y) 2025 Capital Markets Day November 20, 2025 04:00 AM ET Speaker1Good morning, everyone, and welcome. I'm really pleased to host you today here in the heart of Corbion, in our Gorinchem facility. This is one of our most important manufacturing facilities, but also one of the most important innovation centers we have across the company. Let me begin now with a brief recap of Advance 2025 and the major achievements we've delivered. I'll turn into the future and why we have every reason to ...

BRIGHT 2030 Strategy & Financial Targets - The company aims for organic sales growth of 3-6% per annum from 2026-2028[6, 100, 123, 145] - The company targets an adjusted EBITDA margin of approximately 18% in 2028[6, 100, 123, 145] - The company projects a cumulative free cash flow of approximately €270 million over three years (2026-2028)[6, 100, 123, 145] - The company is targeting a double-digit percentage growth in EPS (Earnings Per Share) per annum from 2026-2028[123, 143, 145] - The company aims for a ROCE (Return on Capital Employed) of approximately 13% by 2028[123] Business Segment Performance & Growth - Food sales reached €769 million in 2024[41, 42, 126] - Nutrition sales reached €157 million in 2024[59, 60, 126] - Biomedical Polymers sales reached €55 million in 2024, with a target of €125 million by 2030[89, 94] - The company's natural food preservation market share is 25%[44] - The company projects to grow the Food business to €1 billion by 2030, representing approximately 4% CAGR[53, 54] - The company projects over €100 million additional Nutrition sales in the coming 5 years, reaching €275 million by 2030, representing approximately 10% CAGR[82] Sustainability & Operations - The company sources 98% of its raw materials from renewable sources[27, 33] - The company aims for a 42% reduction in Scope 1 & 2 emissions and a 25% reduction in Scope 3 emissions by 2030[29]